ProShares Ultra Nasdaq Biotechnology

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®.
The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.

Key stats

Management firm  ProShares
Domicile  United States
Fund Administrator  J. P. Morgan Chase Bank, N.A.
Global Branding Name  ProShares
Fund currency  USD
Launch Date  2010-04-06
ISIN  US74347R2141
SEDOL  B5VRWL9
Manager 1 Name  Charles Lowery
Manager 2 Name  Michael Neches
Fund Strategy  Trading-Leveraged Equity
Benchmark  NASDAQ Biotechnology TR USD
Fund Structure  Open Ended Investment Company
UCITS 3 compliant  no

Performance/Volatility

Return Date  2014-06-30
Return - 1 Month  14.97%
Return - 2 Months  24.37 %
Return - 3 Months  16.17%
Return - 6 Months  23.26 %
Return - 9 months  41.93 %
Return - 12 Months  104.49%
Annualized return 24 months  87.79 %
Annualized return 36 months  69.07 %
Annualized return 48 months  72.88 %
Annualized return 60 months  0.00 %
Return 120 months  0.00 %
Annualized return since Inception  53.88%
Return YTD  23.26%

Charges

Initial  0.00 %
Maximum Managment Charge  0.75 %
Exit charge  0.00 %
Performance Fee  0.00 %

Contact

Contact Address  ProShares
Contact Address 2  7501 Wisconsin Avenue, Suite 1000
Contact Address 3  Bethesda, MD 20814
Contact city  Bethesda
Contact country  United States
Fund Admin Group  ProShares
Web Address  www.proshares.com
Custodian  J. P. Morgan Chase Bank, N.A.
Phone  (866) 776-5125

Price

Last Price Date  2014-07-17
Pre-tax nav  82.91
Pre-tax offer  83.95
Pre-tax bid  82.40
Pre-tax mid  0.00
Post-tax nav  0.00
Post-tax offer  0.00
Post-tax bid  0.00
Price change  $-4.00
Price change (percentage)  -4.60 %
Guaranteed NAV  0.00000
Close Price  0.00

Funds Disclaimer

© 2011 - Morningstar UK Limited. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar; (2) may not be copied or distributed (save (i) as incidentally necessary in the course of viewing it on-line (ii) in the course of printing off single copies of web pages on which it appears for the use of those authorised to view it on-line), or adapted in any way (3) is not warranted to be accurate, complete or timely. This Morningstar-sourced information is provided to you by GFM Ltd and is at your own risk. You agree that Morningstar and or GFM Ltd are not responsible for any damages or losses arising from any use of this information and that the information must not be relied upon by you the user without appropriate verification. GFM Ltd informs you as follows: (i) The information provided should not form the sole basis of any investment decision (ii) no investment decision should be made in relation to any of the information provided other than on the advice of a professional financial advisor; (iii) past performance is no guarantee of future results; and (iv) the value and income derived from investments can go down as well as up.
For fund additions and/or data corrections please contact dataquestions@morningstar.com

Ratings Disclaimer

© 2010 - 2011 Morningstar UK Limited. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.
For fund additions and/or data corrections please contact dataquestions@morningstar.com

All our data is licensed from Morningstar UK Ltd. Important legal information